998 F.3d 1337
Fed. Cir.2021Background
- Parties: Becton, Dickinson & Co. (petitioner/appellant) challenged Baxter Corp. Englewood’s U.S. Patent No. 8,554,579 in an inter partes review; Federal Circuit reviews Board decision.
- Patent: ’579 patent claims a telepharmacy/system for preparing patient‑specific doses; two contested claim limitations were (1) a verification limitation requiring each step be verified before proceeding, and (2) a highlighting limitation requiring an interactive screen with prompts that can be highlighted for additional information.
- IPR: Becton petitioned to invalidate claims 1–13 and 22, relying principally on Alexander, Liff, and Morrison. The Board found motivation to combine but held Alexander did not teach the verification limitation and combinations did not teach the highlighting limitation, and deemed Baxter’s secondary‑consideration evidence weak.
- Claim construction: Board applied the broadest reasonable interpretation (BRI) and construed the verification limitation to mean the system will not allow the operator to proceed to the next step until the prior step has been verified.
- Federal Circuit action: On appeal the Federal Circuit concluded the Board’s findings on both limitations were not supported by substantial evidence, held Alexander (and Alexander+Liff) rendered the limitations obvious, and reversed the Board.
Issues
| Issue | Becton (petitioner) argument | Baxter (patent owner) argument | Held |
|---|---|---|---|
| Whether Alexander teaches/ renders obvious the verification limitation (system prevents proceeding until prior step verified) | Alexander discloses remote pharmacist verifying each step and authorizing further processing; thus it teaches a verification before proceeding | Alexander lacks a mechanical ‘‘hard stop’’ and describes optional/occasional verification; ’579 is an improvement over prior ‘‘pull‑back’’ methods | Reversed Board: Alexander discloses systematic step‑by‑step verification that authorizes continuation; substantial‑evidence lacking for Board’s contrary finding; limitation obvious over Alexander |
| Whether highlighting limitation (interactive screen with highlightable prompts revealing more info) is obvious over Alexander+Liff (and Morrison) | Liff teaches screen highlighting; a person of ordinary skill would add tabs/ detail info to Liff’s UI for drug preparation, rendering ’579 highlighting predictable | Highlighting in Liff concerns patient characteristics in a different context; the Board found no explanation why that would lead to highlighting prompts for particular drug preparation steps | Reversed Board: combining Alexander and Liff would have made highlighting limitation obvious; Board erred in requiring Liff alone to specify the exact additional information |
| Whether Alexander qualifies as prior art under pre‑AIA 35 U.S.C. § 102(e)(2) given later cancellation of its claims | Alexander’s application matured into a granted patent before the ’579 filing date and so is §102(e)(2) prior art | Alexander’s grant was later revoked (claims cancelled), so it should not qualify as a granted patent for prior‑art status | Court: §102(e)(2) requires that a patent was "granted" (which occurred); later invalidation does not negate that historical grant for prior art status |
| Whether Baxter’s secondary considerations overcome the prima facie obviousness showing | Secondary considerations not addressed in detail but do not overcome a strong obviousness showing | Secondary considerations (focused on verification) show improvement over prior art and support non‑obviousness | Court: Board found secondary evidence weak; Baxter does not meaningfully show it could overcome the strong obviousness based on prior art; affirmatively not enough to save claims |
Key Cases Cited
- MCM Portfolio LLC v. Hewlett‑Packard Co., 812 F.3d 1284 (Fed. Cir. 2015) (standard of review: legal questions de novo, factual findings for substantial evidence)
- KSR Int’l Co. v. Teleflex Inc., 550 U.S. 398 (2007) (familiar elements combined by known methods producing predictable results supports obviousness)
- Graham v. John Deere Co. of Kansas City, 383 U.S. 1 (1966) (framework for obviousness inquiry, including secondary considerations)
- Hazeltine Research, Inc. v. Brenner, 382 U.S. 252 (1965) (prior‑art timing and publication principles relevant to §102 analysis)
- ZUP, LLC v. Nash Mfg., Inc., 896 F.3d 1365 (Fed. Cir. 2018) (weak secondary‑consideration evidence cannot overcome strong obviousness showing)